Inhibitors

Inhibitor refers to substance that can hinder the chemical reactions, biological reactions (including immune response) and biological activity. In present time, commonly used inhibitors include immunosuppressants and inhibitors.

1. Immunosuppressive agents: immunosuppressants system refers to drug that can reduce the immune response. It can selectively suppress certain steps of the immune response and immune cells. Immune response refers to the body’s response to a variety of pathogenic substances. Some reactions are favorable to the body and can enhance the body's resistance to disease; some have adverse effects on the body and can cause tissue damage or disorders of physiological functions (allergy). Therefore, patients suffering from allergic reactions being harmful to the body should be subject to the treatment of immunosuppressant to affect the related immune processes and reduce the immune response of the body.

For the treatment of various autoimmune diseases and weakening the tissue incompatibility, it has been developed of a variety of immunosuppressive agents, some of which have been widely used in clinical practice. Commonly used immunosuppressants include glucocorticoids (prednisone, prednisolone, etc.), alkylating agents (nitric oxide mustard, cyclophosphamide, thiotepa, busulfan, etc.), and antimetabolites (6- mercaptopurine, azathioprine, methotrexate, etc.).

The mechanism of immunosuppressants, though not entirely clear, but is characterized by the following several aspects:
① most kinds of immunosuppressants can simultaneously inhibit cellular and humoral immunity and can be used for organ transplantation and autoimmune disease.
②Its inhibitory effect is strong for the primary immune response while the inhibitory effect against secondary response is weak.
③It can simultaneously act on normal and pathological immunity, therefore, can often lead to some complications.
④These drugs often have strong with serious adverse reactions.

2. Enzyme inhibitors: Enzyme inhibitors refer to compounds or drugs being capable of binding to enzyme and inhibit the enzymatic activity. It is clinically often applied of enzyme inhibitors to specially interfere with certain metabolic system to achieve the therapeutic purposes. For example, people use monoamine oxidase inhibitors as antidepressants; use carbonic anhydrase inhibitors as diuretics; use dopa decarboxylase inhibitors as antihypertensive drugs and use antibiotics such as penicillin, cephalosporins belonging to cell wall synthesis inhibitors. Enzyme inhibitors have applications in veterinary medicine and agriculture. In addition, people can also apply enzyme inhibitors to study the mechanism of the enzyme and metabolic pathways.

Enzyme inhibitors often have similar structure with their natural substrates. For designing the inhibitors according modification of natural substrate, people should first analyze and decide the function of each part of the molecule in binding with enzymes: for binding or not binding or repulsion; secondly, people should know the degree of tolerance of the binding site to the adjacent steric hindrance. Then people can replace each functional group to regulate the strength of interaction with the enzyme.

Inhibitors can be divided into reversible and irreversible, two classes. (1)Inhibitors binding with enzyme through non-covalent bonds are called reversible inhibitor. (2)Inhibitors binding to the enzyme via a covalent bond are irreversible inhibitors with strong binding affinity. They will not be affected by concentration change process such as dialysis or dilution after binding to the enzyme.

Click on the specific product, view the latest prices of the products, information, serving information
Structure Chemical Name CAS MF
BML-190 BML-190 2854-32-2 C23H23ClN2O4
GNF-2 GNF-2 778270-11-4 C18H13F3N4O2
Mozavaptan Mozavaptan 137975-06-5 C27H29N3O2
NVP-LDE225 NVP-LDE225 956697-53-3 C26H26F3N3O3
SB271046 SB271046 209481-20-9 C20H22ClN3O3S2
PHA-793887 PHA-793887 718630-59-2 C19H31N5O2
SB 743921 SB 743921 940929-33-9 C31H34Cl2N2O3
Fostamatinib Fostamatinib 901119-35-5 C23H26FN6O9P
MK-0822 MK-0822 603139-19-1 C25H27F4N3O3S
GDC-0068 GDC-0068 1001264-89-6 C24H32ClN5O2
N-cyclohexyl-2-(N-(3-fluorophenyl)-2-(2-Methyl-1H-iMidazol-1-yl)acetaMido)-2-(o-tolyl)acetaMide N-cyclohexyl-2-(N-(3-fluorophenyl)-2-(2-Methyl-1H-iMidazol-1-yl)acetaMido)-2-(o-tolyl)acetaMide 1355326-35-0 C27H31FN4O2
3-Amino-6-[4-(methylsulfonyl)phenyl]-N-phenyl-2-pyrazinecarboxamide 3-Amino-6-[4-(methylsulfonyl)phenyl]-N-phenyl-2-pyrazinecarboxamide 1232410-49-9 C18H16N4O3S
GSK2636771 GSK2636771 1372540-25-4 C22H22F3N3O3
Trelagliptin Trelagliptin 865759-25-7 C18H20FN5O2
RVX-208 RVX-208 1044870-39-4 C20H22N2O5
LY 2784544 LY 2784544 1229236-86-5 C23H25ClFN7O
PD04217903 PD04217903 956905-27-4 C19H16N8O
PaloMid 529 (P529) PaloMid 529 (P529) 914913-88-5 C24H22O6
BIO BIO 667463-62-9 C16H10BrN3O2
Tipifarnib Tipifarnib 192185-72-1 C27H22Cl2N4O
Calpain Inhibitor I Calpain Inhibitor I 110044-82-1 C20H37N3O4
Ulipristal Ulipristal 159811-51-5 C28H35NO3
U-73122 U-73122 112648-68-7 C29H40N2O3
JNJ-7706621 JNJ-7706621 443797-96-4 C15H12F2N6O3S
BIIB-021 BIIB-021 848695-25-0 C14H15ClN6O
(5Z)-5-[[3-(Trifluoromethyl)phenyl]methylene]-2,4-thiazolidinedione (5Z)-5-[[3-(Trifluoromethyl)phenyl]methylene]-2,4-thiazolidinedione 438190-29-5 C11H6F3NO2S
N1,N4-Di-2-pyridinyl-1,4-benzenedimethanamine N1,N4-Di-2-pyridinyl-1,4-benzenedimethanamine 55778-02-4 C18H18N4
(R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid (R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid 1072833-77-2 C14H19BCl2N2O4
Cobicistat Cobicistat 1004316-88-4 C40H53N7O5S2
ABT-199 ABT-199 1257044-40-8 C45H50ClN7O7S
TCID TCID 30675-13-9 C9H2Cl4O2
Z-DEVD-FMK Z-DEVD-FMK 210344-95-9 C30H41FN4O12
Epothilone A Epothilone A 152044-53-6 C26H39NO6S
Ki8751 Ki8751 228559-41-9 C24H18F3N3O4
GW9508 GW9508 885101-89-3 C22H21NO3
PAC1 PAC1 315183-21-2 C23H28N4O2
(2R)-1-[[5-[(Z)-[5-[[(2,6-DICHLOROPHENYL)METHYL]SULFONYL]-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE]METHYL]-2,4-DIMETHYL-1H-PYRROL-3-YL]CARBONYL]-2-(1-PYRROLIDINYLMETHYL)PYRROLIDINE (2R)-1-[[5-[(Z)-[5-[[(2,6-DICHLOROPHENYL)METHYL]SULFONYL]-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE]METHYL]-2,4-DIMETHYL-1H-PYRROL-3-YL]CARBONYL]-2-(1-PYRROLIDINYLMETHYL)PYRROLIDINE 477575-56-7 C32H34Cl2N4O4S
42-(Dimethylphosphinate)rapamycin 42-(Dimethylphosphinate)rapamycin 572924-54-0 C53H84NO14P
(S)-1-((S)-2-(4-amino-3-chlorobenzamido)-3,3-dimethylbutanoyl)-N-((2R,3S)-2-ethoxy-5-oxotetrahydrofuran-3-yl)pyrrolidine-2-carboxamide (S)-1-((S)-2-(4-amino-3-chlorobenzamido)-3,3-dimethylbutanoyl)-N-((2R,3S)-2-ethoxy-5-oxotetrahydrofuran-3-yl)pyrrolidine-2-carboxamide 273404-37-8 C24H33ClN4O6
N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide 875337-44-3 C26H20FN5O2S2
LY2886721 LY2886721 1262036-50-9 C18H16F2N4O2S
Apatinib Apatinib 811803-05-1 C24H23N5O
Indacaterol Maleate Indacaterol Maleate 753498-25-8 C28H32N2O7
S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide 1346574-57-9 C31H38N6O2
BMY 7378 DIHYDROCHLORIDE BMY 7378 DIHYDROCHLORIDE 21102-95-4 C22H32ClN3O3
TYRPHOSTIN AG 1296 TYRPHOSTIN AG 1296 146535-11-7 C16H14N2O2
4-BENZYL-2-METHYL-1,2,4-THIADIAZOLIDINE-3,5-DIONE 4-BENZYL-2-METHYL-1,2,4-THIADIAZOLIDINE-3,5-DIONE 327036-89-5 C10H10N2O2S
ROTIGOTINE ROTIGOTINE 99755-59-6 C19H25NOS
DAPIVIRINE,4-[[4-(2,4,6-TRIMETHYLPHENYL)AMINO]PYRIMIDIN-2-YL]AMINO]BENZONITRILE DAPIVIRINE,4-[[4-(2,4,6-TRIMETHYLPHENYL)AMINO]PYRIMIDIN-2-YL]AMINO]BENZONITRILE 244767-67-7 C20H19N5
Aclidinium bromide Aclidinium bromide 320345-99-1 C13H10BrN
cilengitide cilengitide 188968-51-6 C27H40N8O7
ZOSUQUIDAR TRIHYSROCHLORIDE ZOSUQUIDAR TRIHYSROCHLORIDE 167465-36-3 C32H32ClF2N3O2
5-[[5-(4-Fluoro-2-hydroxyphenyl)-2-furanyl]methylene]-2,4-thiazolidinedione 5-[[5-(4-Fluoro-2-hydroxyphenyl)-2-furanyl]methylene]-2,4-thiazolidinedione 900515-16-4 C14H8FNO4S
Y27632 (hydrochloride) Y27632 (hydrochloride) 129830-38-2 C14H23Cl2N3O
yk11 yk11 1370003-76-1 C25H34O6
3,4-Methylenedioxy-N-benzylcathinone (hydrochloride) 3,4-Methylenedioxy-N-benzylcathinone (hydrochloride) 1823274-68-5 C17H18ClNO3
Eptifibatide Eptifibatide 148031-34-9 C35H49N11O9S2
Belzutifan Belzutifan 1672668-24-4 C17H12F3NO4S
Metonitazene Metonitazene 14680-51-4 C21H26N4O3
 ALC-0315 ALC-0315 2036272-55-4 C48H95NO5
Indacaterol Indacaterol 312753-06-3 C24H28N2O3
LY-2484595 LY-2484595 1186486-62-3 C31H36F6N6O2
MLN9708 MLN9708 1201902-80-8 C20H23BCl2N2O9
GSK1292263 GSK1292263 1032823-75-8 C23H28N4O4S
OC000459 OC000459 851723-84-7 C21H17FN2O2
Baricitinib Baricitinib 1187594-09-7 C16H17N7O2S
ACY-1215 ACY-1215 1316214-52-4 C24H27N5O3
Lurbinectedin Lurbinectedin 497871-47-3 C41H44N4O10S
PR-619 PR-619 2645-32-1 C7H5N5S2
2-(4-broMo-2-chlorophenoxy)-N-(4-(N-(4,6-diMethylpyriMidin-2-yl)sulfaMoyl)phenylcarbaMothioyl)acetaMide 2-(4-broMo-2-chlorophenoxy)-N-(4-(N-(4,6-diMethylpyriMidin-2-yl)sulfaMoyl)phenylcarbaMothioyl)acetaMide 587841-73-4 C21H19BrClN5O4S2
ASP-2215 ASP-2215 1254053-43-4 C29H44N8O3
Oclacitinib maleate Oclacitinib maleate 1640292-55-2 C19H27N5O6S
TYRPHOSTIN AG 879 TYRPHOSTIN AG 879 148741-30-4 C18H24N2OS
BLASTICIDIN S HYDROCHLORIDE BLASTICIDIN S HYDROCHLORIDE 3513-03-9 C17H27ClN8O5
BOC-(R)-3-AMINO-4-(2,4,5-TRIFLUORO-PHENYL)-BUTYRIC ACID BOC-(R)-3-AMINO-4-(2,4,5-TRIFLUORO-PHENYL)-BUTYRIC ACID 486460-00-8 C15H18F3NO4
PP1 PP1 172889-26-8 C16H19N5
DIPENTAERYTHRITOL HEXAKIS(3-MERCAPTOPROPIONATE) DIPENTAERYTHRITOL HEXAKIS(3-MERCAPTOPROPIONATE) 25359-71-1 C28H46O13S6
Dexmedetomidine Dexmedetomidine C13H16N2
ZM 447439 ZM 447439 331771-20-1 C29H31N5O4
N-(5-CHLORO-2,4-DIMETHOXYPHENYL)-N'-(5-METHYL-3-ISOXAZOLYL)-UREA N-(5-CHLORO-2,4-DIMETHOXYPHENYL)-N'-(5-METHYL-3-ISOXAZOLYL)-UREA 501925-31-1 C13H14ClN3O4
MRTX1133 MRTX1133 2621928-55-8 C33H31F3N6O2
PJ-34 PJ-34 344458-15-7 C17H17N3O2HCl
Exatecan Exatecan 171335-80-1 C24H22FN3O4
somatotropin (176-191) somatotropin (176-191) 66004-57-7 C78H123N23O22S2
Ginsenoside CK Ginsenoside CK 39262-14-1 C36H62O8
TENOVIN-1 TENOVIN-1 380315-80-0 C20H23N3O2S
BX-912 BX-912 702674-56-4 C20H23BrN8O
KU57788(NU7441) KU57788(NU7441) 503468-95-9 C25H19NO3S
AZD 1480 AZD 1480 935666-88-9 C14H14ClFN8
RAF265(CHIR-265) RAF265(CHIR-265) 927880-90-8 C24H16F6N6O
AZD-4547 AZD-4547 1035270-39-3 C26H33N5O3
I-BET151 (GSK1210151A) I-BET151 (GSK1210151A) 1300031-49-5 C23H21N5O3
ARN-509 ARN-509 956104-40-8 C21H15F4N5O2S
Elagolix Sodium Elagolix Sodium 832720-36-2 C32H29F5N3NaO5
IFENPRODIL HEMITARTRATE IFENPRODIL HEMITARTRATE 23210-58-4 C25H33NO8
Siremadlin Siremadlin 1448867-41-1 C26H24Cl2N6O4
4-Butylresorcinol 4-Butylresorcinol 18979-61-8 C10H14O2
AR-A014418 AR-A014418 487021-52-3 C12H12N4O4S
4-Morpholinecarboxylic acid, 2-[[2-[2,6-difluoro-4-[(methylamino)carbonyl]phenyl]-7-methylimidazo[1,2-a]pyridin-3-yl]methyl]-, methyl ester, (2S)- 4-Morpholinecarboxylic acid, 2-[[2-[2,6-difluoro-4-[(methylamino)carbonyl]phenyl]-7-methylimidazo[1,2-a]pyridin-3-yl]methyl]-, methyl ester, (2S)- 1621164-74-6 C23H24F2N4O4
JTC 801 JTC 801 244218-51-7 C26H25N3O2.ClH
Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.